Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 62 Records) |
| Query Trace: Adenocarcinoma and EML4[original query] |
|---|
| Programmed death-ligand 1 expression associated with molecular characteristics in surgically resected lung adenocarcinoma. Journal of translational medicine 2016 06 14 (1): 188. Song Zhengbo, Yu Xinmin, Cheng Guoping, Zhang Yipi |
| Distinct epithelial growth factor receptor mutation profile in non-small-cell lung cancer patients from the Xuanwei area of China. Molecular and clinical oncology 2016 May 4 (5): 749-755. Chen Yun, Ye Lijuan, Stanford Rebecca Rongrong, Zhang Dongfang, Zhang Xingsong, Wei Wan |
| Efficacy of Pemetrexed-Based Chemotherapy in Patients with ROS1 Fusion-Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian Populations. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Apr . Chen Yen-Fu, Hsieh Min-Shu, Wu Shang-Gin, Chang Yih-Leong, Yu Chong-Jen, Yang James Chih-Hsin, Yang Pan-Chyr, Shih Jin-Yu |
| [Correlation of clinicopathologic features and driver gene mutation in non-small cell lung cancer]. Zhonghua bing li xue za zhi Chinese journal of pathology 2016 Apr 45 (4): 221-5. Chen L F, Chen X Y, Yu X |
| [Oncogenic drivers in daily practice improve overall survival in patients with lung adenocarcinoma]. Revue des maladies respiratoires 2016 Mar . Fournier C, Greillier L, Fina F, Secq V, Nanni-Metellus I, Loundou A, Garcia S, Ouafik L, Tomasini P, Barlesi |
| Clinicopathological features and relation between anaplastic lymphoma kinase (ALK) mutation and histological subtype of lung adenocarcinoma in Eastern European Caucasian population. Journal of Cancer 2016 7 (15): 2207-2212. Zaric Bojan, Stojsic Vladimir, Panjkovic Milana, Tegeltija Dragana, Stepanov Vanesa, Kovacevic Tomi, Sarcev Tatjana, Radosavljevic Davorin, Milovancev Aleksandar, Adamidis Vasilis, Zarogoulidis Paul, Hohenforst-Schmidt Wolfgang, Trakada Georgia, Rapti Aggeliki, Perin Branisl |
| The expression of SALL4 is significantly associated with EGFR, but not KRAS or EML4-ALK mutations in lung cancer. Journal of thoracic disease 2016 Oct 8 (10): 2682-2688. Jia Xiangbo, Qian Rulin, Zhang Binbin, Zhao So |
| Application of Single-Molecule Amplification and Resequencing Technology for Broad Surveillance of Plasma Mutations in Patients with Advanced Lung Adenocarcinoma. The Journal of molecular diagnostics : JMD 2017 Jan 19 (1): 169-181. Wang Zheng, Cheng Gang, Han Xiaohong, Mu Xinlin, Zhang Yuhui, Cui Di, Liu Chang, Zhang Li, Fan Zaiwen, Ma Lingyun, Yang Li, Di Jing, Cram David S, Shi Yuankai, Liu Dong |
| Prevalence of EGFR and ALK Mutations in Lung Adenocarcinomas in the Levant Area - a Prospective Analysis Asian Pacific journal of cancer prevention : APJCP 2017 01 18 (1): 107-114. Tfayli Arafat, Rafei Hind, Mina Alain, Khalil Maya, Fakhreddin Najla, Mahfouz Rami, Hamouri Shadi, Farhat Fadi, Salem Ziad, Dbouk Haifa, Rabee Haider, Saghir Nagi, Shamseddine Ali, Makarem Jawad, Bitar Nizar, Mougharbil Anas, Assi Hazem, Temraz Sally, Mukherji Deborah, Matalka Ismail, Zaatari Gha |
| An international epidemiological analysis of young patients with non-small cell lung cancer (AduJov-CLICaP). Lung cancer (Amsterdam, Netherlands) 2017 11 113 30-36. Corrales-Rodríguez Luis, Arrieta Oscar, Mas Luis, Báez-Saldaña Renata, Castillo-Fernández Omar, Blais Normand, Martín Claudio, Juárez Melissa, Khanna Priyanka, Ramos-Esquivel Allan, Bacon Ludwing, Rojas Leonardo, Wills Beatriz, Oblitas George, Pérez María Angelina, Cuello Mauricio, Cardona Andrés Felipe, |
| [Gene Expression and Clinical Characteristics of Molecular Targeted Therapy ?in Non-small Cell Lung Cancer Patients in Shandong]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2017 Jan 20 (1): 14-20. Qiao Xiuli, Ai Dan, Liang Honglu, Mu Dianbin, Guo Qis |
| Identification of a highly lethal V3 TP53 subset in ALK lung adenocarcinoma. International journal of cancer 2018 Sep . Christopoulos P, Kirchner M, Bozorgmehr F, Endris V, Elsayed M, Budczies J, Ristau J, Penzel R, Herth F J, Heussel C P, Eichhorn M, Muley T, Meister M, Fischer J R, Rieken S, Lasitschka F, Bischoff H, Sotillo R, Schirmacher P, Thomas M, Stenzinger |
| Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion. Genes, chromosomes & cancer 2018 Aug . Wu Shang-Gin, Liu Yi-Nan, Yu Chong-Jen, Yang James Chih-Hsin, Shih Jin-Yu |
| Correlation between EML4-ALK, EGFR and clinicopathological features based on IASLC/ATS/ERS classification of lung adenocarcinoma. Medicine 2018 Jun 97 (26): e11116. Wang Hongyan, Zhang Wen, Wang Kai, Li Xiaofe |
| Characteristics of genomic alterations of lung adenocarcinoma in young never-smokers. International journal of cancer 2018 4 143 (7): 1696-1705. Luo Wenxin, Tian Panwen, Wang Yue, Xu Heng, Chen Lu, Tang Chao, Shu Yang, Zhang Shouyue, Wang Zhoufeng, Zhang Jun, Zhang Li, Jiang Lili, Liu Lunxu, Che Guowei, Guo Chenglin, Zhang Hong, Wang Jiali, Li Weim |
| Clinicopathological features of younger (aged ? 50 years) lung adenocarcinoma patients harboring the EML4-ALK fusion gene. Thoracic cancer 2018 Mar . Kometani Takuro, Sugio Kenji, Osoegawa Atsushi, Seto Takashi, Ichinose Yuki |
| Response to crizotinib in a non-small-cell lung cancer patient harboring an EML4-ALK fusion with an atypical LTBP1 insertion. OncoTargets and therapy 2018 3 11 1117-1120. Aguado Cristina, Gil Maria-de-Los-Llanos, Yeste Zaira, Giménez-Capitán Ana, Teixidó Cristina, Karachaliou Niki, Viteri Santiago, Rosell Rafael, Molina-Vila Miguel |
| Concomitant EGFR Mutation and EML4-ALK Rearrangement in Lung Adenocarcinoma Is More Frequent in Multifocal Lesions. Clinical lung cancer 2019 Apr . Fan Jun, Dai Xiaofang, Wang Zhenkao, Huang Bo, Shi Heshui, Luo Danju, Zhang Jiwei, Cai Weijing, Nie Xiu, Hirsch Fred |
| Lung cancer family history and exposure to occupational/domestic coal combustion contribute to variations in clinicopathologic features and gene fusion patterns in non-small cell lung cancer. Thoracic cancer 2019 (4): 695-707. Chen Ying, Li Guangjian, Lei Yujie, Yang Kaiyun, Niu Huatao, Zhao Jie, He Rui, Ning Huanqi, Huang Qiubo, Zhou Qinghua, Huang Yunch |
| PTK7 expression is associated with lymph node metastasis, ALK and EGFR mutations in lung adenocarcinomas. Histology and histopathology 2019 11 35 (5): 489-495. Jiang Wei, He Jing, Lv Bihong, Xi Xiaoxiang, He Guangming, He Jingka |
| Clinicopathological and Prognostic Significance of the EML4-ALK Translocation and IGFR1, TTF1, Napsin A Expression in Patients with Lung Adenocarcinoma. Turk patoloji dergisi 2020 9 37 (1): 7-17. Bulutay P?nar, AkyÜrek Nalan, Memi? Ley |
| Different driver gene mutations in patients with synchronous multiple primary lung cancers: a case report. Journal of cardiothoracic surgery 2020 Jul 15 (1): 196. Yang Yong, Xie Xiaofeng, Jiang Gening, Liu Hongche |
| A comprehensive study on the oncogenic mutation and molecular pathology in Chinese lung adenocarcinoma patients. World journal of surgical oncology 2020 Jul 18 (1): 172. Zhang Xilin, Jiang Yan, Yu Huanming, Xia Hui, Wang Xia |
| Multiplexed molecular profiling of lung cancer with malignant pleural effusion using next generation sequencing in Chinese patients. Oncology letters 2020 4 19 (5): 3495-3505. Ruan Xingya, Sun Yonghua, Wang Wei, Ye Jianwei, Zhang Daoyun, Gong Ziying, Yang Mingx |
| Distribution of EML4-ALK fusion variants and clinical outcomes in patients with resected non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2020 10 149 154-161. Tao Hong, Shi Liang, Zhou Aoxue, Li Hongxia, Gai Fei, Huang Zhan, Che Nanying, Liu Z |
| Identification of a EML4-ALK exon 19 fusion variant in lung adenocarcinoma and alectinib resistance. Lung cancer (Amsterdam, Netherlands) 2021 8 160 32-35. Liu Di, Xu Xinyan, Wen Junmiao, Zhang Chi, Fan M |
| Relationship between clinical features and gene mutations in non-small cell lung cancer with osteoblastic bone metastasis. Cancer treatment and research communications 2021 Jul 28 100440. Takahara Yutaka, Nakase Keisuke, Nojiri Masafumi, Kato Ryo, Shinomiya Shohei, Oikawa Taku, Mizuno Shi |
| Analysis of real-word mutations of lung cancer driver genes in five regions of China. Translational cancer research 2022 2 8 (7): 2581-2592. Sun Mengyao, Guo Ye, Shao Guoguang, Duan Xiumei, Yang Zhiguang, Zhang Peng, Liu Yunpeng, Dong Yutong, Wang Xu, Xu Yinghui, Sun Chao, Ma Kew |
| Dual drive coexistence of ALK rearrangement and KRAS mutation advanced lung adenocarcinoma and response to crizotinib. Translational cancer research 2022 2 8 (4): 1630-1634. Zhu You-Cai, Wan Bing, Wu Li-Xin, Li Xing-Liang, Wang Wen-Xian, Xu Chun-Wei, Zhuang Wu, Wei Jian-Guo, Du Kai- |
| Next Generation Sequencing Analysis and its Benefit for Targeted Therapy of Lung Adenocarcinoma. Cancer genomics & proteomics 2023 7 20 (4): 404-411. Vlastimil Kulda, Jiri Polivka, Martin Svaton, Tomas Vanecek, Marcela Buresova, Katerina Houfkova, Mahyar Sharif Bagheri, Tereza Knizkova, Bohuslava Vankova, Jindra Windrichova, Petr Macan, Vaclav Babuska, Martin Pes |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 04, 2023
- Content source: